• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病确诊后 5 年内,HbA 很少出现有临床意义且持久的改善:这表明应尽早进行有针对性且积极的干预。

Clinically meaningful and lasting HbA improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

机构信息

Department of Diabetes, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Public Health, Epidemiology and Biostatistics, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.

出版信息

Diabetologia. 2018 May;61(5):1064-1070. doi: 10.1007/s00125-018-4574-6. Epub 2018 Feb 24.

DOI:10.1007/s00125-018-4574-6
PMID:29478098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448997/
Abstract

AIMS/HYPOTHESIS: Our objectives were to explore whether the phenomenon of HbA 'tracking' occurs in individuals with type 1 diabetes, how long after diagnosis does tracking take to stabilise, and whether there is an effect of sex and age at diagnosis on tracking.

METHODS

A total of 4525 individuals diagnosed with type 1 diabetes between 1 January 1995 and 1 May 2015 were identified from The Health Improvement Network (THIN) database. Mixed models were applied to assess the variability of HbA levels over time with random effects on general practices (primary care units) and individuals within practices.

RESULTS

4525 individuals diagnosed with type 1 diabetes were identified in THIN over the study period. The greatest difference in mean HbA measurement (-7.0 [95% CI -8.0, -6.1] mmol/mol [0.6%]) was seen when comparing measurements made immediately after diagnosis (0-1 year since diagnosis) with those at 10 or more years (the reference category). The mean difference in HbA for the successive periods compared with 10 or more years after diagnosis declined and was no longer statistically significant after 5 years. In the stratified analysis using sex and age group there was considerable heterogeneity with adult onset type 1 diabetes appearing to track earlier and at a lower mean HbA.

CONCLUSIONS/INTERPRETATION: In individuals with type 1 diabetes, glycaemic control measured by HbA settles onto a long-term 'track' and this occurs on average by 5 years following diagnosis. Age at diagnosis modifies both the rate at which individuals settle into their track and the absolute HbA tracking level for the next 10 years.

摘要

目的/假设:我们的目的是探讨 1 型糖尿病患者是否存在 HbA“跟踪”现象,跟踪需要多长时间才能稳定,以及性别和诊断时的年龄是否对跟踪有影响。

方法

从健康改善网络(THIN)数据库中确定了 1995 年 1 月 1 日至 2015 年 5 月 1 日期间诊断为 1 型糖尿病的 4525 名个体。混合模型用于评估个体内和个体间实践的 HbA 水平随时间的变化,随机效应为一般实践(初级保健单位)。

结果

在研究期间,THIN 中确定了 4525 名诊断为 1 型糖尿病的个体。与诊断后 10 年或更长时间(参考类别)相比,诊断后 0-1 年内(即诊断后即刻)测量的平均 HbA 差值最大(-7.0 [95%CI-8.0,-6.1]mmol/mol [0.6%])。与诊断后 10 年或更长时间相比,连续各期的 HbA 平均差异下降,5 年后不再具有统计学意义。在使用性别和年龄组进行的分层分析中,存在相当大的异质性,成年发病的 1 型糖尿病似乎更早且平均 HbA 水平更低地跟踪。

结论/解释:在 1 型糖尿病患者中,HbA 测量的血糖控制稳定在一个长期的“轨道”上,平均在诊断后 5 年达到。诊断时的年龄既改变了个体进入轨道的速度,也改变了接下来 10 年的绝对 HbA 跟踪水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/c70b4c04ccf7/125_2018_4574_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/e89ddba988a2/125_2018_4574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/6496cc36c43c/125_2018_4574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/c70b4c04ccf7/125_2018_4574_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/e89ddba988a2/125_2018_4574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/6496cc36c43c/125_2018_4574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c0/6448997/c70b4c04ccf7/125_2018_4574_Fig3_HTML.jpg

相似文献

1
Clinically meaningful and lasting HbA improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.1 型糖尿病确诊后 5 年内,HbA 很少出现有临床意义且持久的改善:这表明应尽早进行有针对性且积极的干预。
Diabetologia. 2018 May;61(5):1064-1070. doi: 10.1007/s00125-018-4574-6. Epub 2018 Feb 24.
2
Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.HbA1c 变化及确诊 2 型糖尿病后 10 年内 HbA1c 测量频率和降糖药物调整情况:英国一项基于人群的研究。
Diabetologia. 2014 Aug;57(8):1586-94. doi: 10.1007/s00125-014-3250-8. Epub 2014 May 9.
3
Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.血糖控制不佳与儿童期起病 1 型糖尿病患者神经发育障碍风险增加相关:一项基于人群的队列研究。
Diabetologia. 2021 Apr;64(4):767-777. doi: 10.1007/s00125-020-05372-5. Epub 2021 Jan 16.
4
Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.糖尿病酮症酸中毒严重程度诊断与儿童期起病 1 型糖尿病患者血糖控制:一项纵向队列研究。
Int J Environ Res Public Health. 2017 Dec 25;15(1):26. doi: 10.3390/ijerph15010026.
5
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.1 型糖尿病成人中闪光血糖监测的效果:一项全国性、纵向观察研究,比较了 14372 名闪光血糖监测使用者和 7691 名葡萄糖传感器无经验对照者。
Diabetologia. 2021 Jul;64(7):1595-1603. doi: 10.1007/s00125-021-05437-z. Epub 2021 Mar 27.
6
Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.2004-2016 年苏格兰 1 型糖尿病患者血糖控制趋势。
Diabetologia. 2019 Aug;62(8):1375-1384. doi: 10.1007/s00125-019-4900-7. Epub 2019 May 18.
7
Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013-22): a longitudinal analysis of data from paediatric diabetes registries.10万多名1型糖尿病儿童的治疗方案与血糖结果(2013 - 2022年):来自儿科糖尿病登记处数据的纵向分析
Lancet Diabetes Endocrinol. 2025 Jan;13(1):47-56. doi: 10.1016/S2213-8587(24)00279-1. Epub 2024 Nov 29.
8
First year national Swedish paediatric Hba1c data are at the level of several intervention studies: Results from a Swedish nationwide diabetes register study.瑞典全国儿科 Hba1c 的第一年数据达到了几项干预研究的水平:来自瑞典全国糖尿病登记研究的结果。
Diabetes Res Clin Pract. 2024 Oct;216:111807. doi: 10.1016/j.diabres.2024.111807. Epub 2024 Aug 6.
9
Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study.儿童期发病 1 型糖尿病患者发生严重视网膜病变的长期风险:一项数据关联研究。
Med J Aust. 2017 May 15;206(9):398-401. doi: 10.5694/mja16.00712.
10
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system.使用美敦力780G系统对1型糖尿病且糖化血红蛋白(HbA1c)水平极高的儿童和青年患者血糖改善的预测因素
Diabetes Obes Metab. 2025 Apr;27(4):2138-2146. doi: 10.1111/dom.16210. Epub 2025 Jan 20.

引用本文的文献

1
ROCKET T1D Remote Patient Monitoring Program: Launching Diabetes Management Habits in New-Onset Diabetes.ROCKET T1D远程患者监测项目:在新发糖尿病中培养糖尿病管理习惯。
Clin Diabetes. 2025 Feb 11;43(3):371-377. doi: 10.2337/cd24-0065. eCollection 2025 Summer.
2
Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes.1型糖尿病儿童和青少年早期持续血糖监测的启动率及其对血糖结果的影响
Diabetes Care. 2025 May 1;48(5):768-775. doi: 10.2337/dc25-0076.
3
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

本文引用的文献

1
All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study.胰高血糖素样肽-1激动剂治疗的糖尿病患者的全因死亡率:一项基于人群的开放性队列研究。
Diabetes Metab. 2017 Jun;43(3):211-216. doi: 10.1016/j.diabet.2017.02.003. Epub 2017 Mar 18.
2
All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database.达格列净治疗的糖尿病患者的全因死亡率:基于健康改善网络数据库的一项人群开放性队列研究
J Clin Endocrinol Metab. 2017 May 1;102(5):1719-1725. doi: 10.1210/jc.2016-3446.
3
国际儿童和青少年糖尿病学会2024年临床实践共识指南:糖尿病技术之血糖监测
Horm Res Paediatr. 2024;97(6):615-635. doi: 10.1159/000543156. Epub 2025 Jan 30.
4
Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes.新诊断为 1 型糖尿病患者的血糖管理精准数字健康计划的公平实施。
Nat Med. 2024 Jul;30(7):2067-2075. doi: 10.1038/s41591-024-02975-y. Epub 2024 May 3.
5
Roadmap to Continuous Glucose Monitoring Adoption and Improved Outcomes in Endocrinology: The 4T (Teamwork, Targets, Technology, and Tight Control) Program.内分泌学中持续葡萄糖监测应用及改善结局路线图:4T(团队合作、目标、技术和严格控制)计划
Diabetes Spectr. 2023 Fall;36(4):299-305. doi: 10.2337/dsi23-0003. Epub 2023 Nov 15.
6
Diabetes Study of Children of Diverse Ethnicity and Race: Study design.不同种族和民族的儿童糖尿病研究:研究设计。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3744. doi: 10.1002/dmrr.3744. Epub 2023 Oct 27.
7
A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes.一项回顾性队列研究,探讨了种族/民族和社会经济差异对 1 型糖尿病青少年连续血糖监测的起始和有意义使用的影响。
J Diabetes Sci Technol. 2024 Nov;18(6):1433-1444. doi: 10.1177/19322968231183985. Epub 2023 Jul 3.
8
Chronic Disease Management of Children Followed with Type 1 Diabetes Mellitus.儿童 1 型糖尿病随访的慢性病管理。
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):172-181. doi: 10.4274/jcrpe.galenos.2023.2022-8-4. Epub 2023 Jan 26.
9
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring.国际儿童青少年糖尿病研究学会(ISPAD)2022年临床实践共识指南:糖尿病技术:血糖监测
Pediatr Diabetes. 2022 Dec;23(8):1390-1405. doi: 10.1111/pedi.13451.
10
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes.国际儿童青少年糖尿病研究学会(ISPAD)2022年临床实践共识指南:糖尿病儿童、青少年及青年的血糖目标与血糖监测
Pediatr Diabetes. 2022 Dec;23(8):1270-1276. doi: 10.1111/pedi.13455.
Longitudinal Trajectories of Metabolic Control From Childhood to Young Adulthood in Type 1 Diabetes From a Large German/Austrian Registry: A Group-Based Modeling Approach.
1 型糖尿病患者从儿童期到青年期代谢控制的纵向轨迹:基于群组的建模方法——来自一个大型德国/奥地利登记处的研究。
Diabetes Care. 2017 Mar;40(3):309-316. doi: 10.2337/dc16-1625. Epub 2016 Dec 22.
4
Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study.1型糖尿病与癫痫发病风险:一项基于人群的开放队列研究。
Diabetologia. 2017 Feb;60(2):258-261. doi: 10.1007/s00125-016-4142-x. Epub 2016 Oct 31.
5
An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database.一种用于在大型初级保健数据库中识别和分类1型和2型糖尿病患者的算法。
Clin Epidemiol. 2016 Oct 12;8:373-380. doi: 10.2147/CLEP.S113415. eCollection 2016.
6
Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.1型糖尿病诊断后最初4年内C肽水平的下降:与年龄、糖化血红蛋白和胰岛素剂量的可变关系。
Diabetes Care. 2016 Oct;39(10):1664-70. doi: 10.2337/dc16-0360. Epub 2016 Jul 15.
7
Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.在1型糖尿病交流诊所登记处的青少年和青年参与者中,糖化血红蛋白(HbA1c)水平随时间变化。
Pediatr Diabetes. 2016 Aug;17(5):327-36. doi: 10.1111/pedi.12295. Epub 2015 Jul 8.
8
CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.连续血糖监测(CGM)测得的血糖值与C肽、糖化血红蛋白(HbA1c)和胰岛素抵抗指数(IDAAC)密切相关,但在预测糖尿病发病后两年内的C肽水平方面表现不佳。
Diabetologia. 2015 Jun;58(6):1167-74. doi: 10.1007/s00125-015-3559-y. Epub 2015 Mar 14.
9
Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study.双膦酸盐与葡萄糖稳态:一项基于人群的回顾性队列研究。
J Clin Endocrinol Metab. 2015 May;100(5):1933-40. doi: 10.1210/jc.2014-3481. Epub 2015 Feb 19.
10
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.21世纪初临床实践中1型糖尿病的血糖控制:一项国际比较。
Diabet Med. 2015 Aug;32(8):1036-50. doi: 10.1111/dme.12676. Epub 2015 Feb 21.